{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T21:14:11Z","timestamp":1762377251650,"version":"3.41.2"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To provide an overview of the range and characteristics of existing evidence, research gaps, and future research priorities in treating amyotrophic lateral sclerosis (ALS) with acupuncture.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Clinical studies on acupuncture treatment for ALS were searched in 9 databases and two websites. Two independent researchers screened the literature according to the inclusion and exclusion criteria; extracted the demographic data, interventions, and significant findings of the studies; and comprehensively analyzed the characteristics and limitations of the included articles.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 2,326 studies were retrieved, of which 92 were included. Most of the studies were conducted in China, with the number increasing over time. Study designs included case reports, case series, randomized controlled trials (RCTs), and before-and-after studies, among which case reports were the most frequently used. A total of 1,388 patients were enrolled, of whom 1,031 had ALS, 274 had progressive bulbar palsy (PBP), 60 had progressive muscle atrophy (PMA), and 23 had primary lateral sclerosis (PLS). Acupuncture interventions included body acupuncture, electroacupuncture, acupoint injection, scalp acupuncture, acupoint massage, Sa-am acupuncture, needle-embedding therapy, auricular acupuncture, venom pharmacopuncture therapy, plum blossom needling, acupoint paste, electroacupuncture, and needle warming through moxibustion. The most frequently used acupoints were ST36, LI4, SP6, and LI11. Acupuncture is often applied in combination with other treatments, such as herbal or Western medicine. The frequency of treatment ranged from once a month to three times a day, and the duration of treatment ranged from 5 days to 3 years. Clinical symptoms, muscle strength, and effective rates were the most frequently used outcomes. Most studies reported significant efficacy, and only a few studies reported adverse events explicitly.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Evidence gaps include poor study design, complex interventions, limited significance of the selected outcomes, and limited study reporting. The promotion of acupuncture treatment for ALS still faces several obstacles. Rigorous study design and conduct, standardized intervention and outcome measurements, and normative reporting are needed to investigate the efficacy and safety of acupuncture treatment for ALS.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2022.1019156","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T06:37:14Z","timestamp":1667457434000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Current state of research on acupuncture for the treatment of amyotrophic lateral sclerosis: A scoping review"],"prefix":"10.3389","volume":"13","author":[{"given":"Siyang","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqian","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaohong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinxia","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenzeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1136\/jnnp.57.8.886","article-title":"Motor neuron disease","volume":"57","author":"Leigh","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B2","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrneurol.2011.153","article-title":"Clinical diagnosis and management of amyotrophic lateral sclerosis","volume":"7","author":"Hardiman","year":"2011","journal-title":"Nat Rev Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S1474-4422(21)00465-8","article-title":"Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis","volume":"21","author":"Goutman","year":"2022","journal-title":"Lancet Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S1474-4422(18)30404-6","volume":"17","year":"2018","journal-title":"Lancet Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S1474-4422(21)00414-2","article-title":"Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis","volume":"21","author":"Goutman","year":"2022","journal-title":"Lancet Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"Cd001447","DOI":"10.1002\/14651858.CD001447.pub3","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","volume":"2012","author":"Miller","year":"2012","journal-title":"Cochrane Database Syst Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/med.21528","article-title":"Riluzole and edaravone: a tale of two amyotrophic lateral sclerosis drugs","volume":"39","author":"Jaiswal","year":"2019","journal-title":"Med Res Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1001\/jamaneurol.2021.4893","article-title":"Safety and effectiveness of long-term intravenous administration of edaravone for treatment of patients with amyotrophic lateral sclerosis","volume":"79","author":"Witzel","year":"2022","journal-title":"JAMA Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.imr.2019.08.003","article-title":"Complementary and alternative medicine for treating amyotrophic lateral sclerosis: a narrative review","volume":"8","author":"Cai","year":"2019","journal-title":"Integr Med Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fncel.2017.00080","article-title":"ALS pathogenesis and therapeutic approaches: the role of mesenchymal stem cells and extracellular vesicles","volume":"11","author":"Bonafede","year":"2017","journal-title":"Front Cell Neurosci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.13460\/j.issn.1005-0957.2019.11.1310","article-title":"Research advances in the mechanism of acupuncture treatment for amyotrophic lateral sclerosis (Chinese)","volume":"38","author":"Zhao","year":"2019","journal-title":"Shanghai J Acupuncture Moxibustion."},{"key":"B12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jneuroim.2010.04.005","article-title":"Electroacupuncture reduces neuroinflammatory responses in symptomatic amyotrophic lateral sclerosis model","volume":"223","author":"Yang","year":"2010","journal-title":"J Neuroimmunol."},{"key":"B13","first-page":"35","article-title":"Effect of Jiaji electro-acupuncture on the apoptosis of lumbar spinal cord motor neurons and the expression of Bax, Bcl-2 and Caspase-3 Proteins for ALS-SOD1G93A transgenic mice (Chinese)","volume":"39","author":"Sun","year":"2021","journal-title":"J Sichuan Tradit Chin Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1089\/acu.2017.1241","article-title":"Amyotrophic lateral sclerosis: an acupuncture approach","volume":"29","author":"Sudhakaran","year":"2017","journal-title":"Med Acupunct."},{"key":"B15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12874-018-0611-x","article-title":"Systematic review or scoping review? guidance for authors when choosing between a systematic or scoping review approach","volume":"18","author":"Munn","year":"2018","journal-title":"BMC Med Res Methodol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"Prisma extension for scoping reviews (Prisma-Scr): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/XEB.0000000000000050","article-title":"Guidance for conducting systematic scoping reviews","volume":"13","author":"Peters","year":"2015","journal-title":"Int J Evid Based Healthc."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.13703\/j.0255-2930.2017.12.020","article-title":"The current situation of acupuncture definition in international organizations and legislation of some countries (Chinese)","volume":"37","author":"Sun","year":"2017","journal-title":"Zhongguo Zhen Jiu."},{"key":"B19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/0022-510X(94)90191-0","article-title":"El escorial world federation of neurology criteria for the diagnosis of amyotrophic lateral sclerosis. subcommittee on motor neuron diseases\/amyotrophic lateral sclerosis of the world federation of neurology research group on neuromuscular diseases and the El escorial \u201cclinical limits of amyotrophic lateral sclerosis\u201d workshop contributors","volume":"124","author":"Brooks","year":"1994","journal-title":"J Neurol Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord."},{"key":"B21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jams.2011.09.017","article-title":"Significant neurological improvement in two patients with amyotrophic lateral sclerosis after 4 weeks of treatment with acupuncture injection point therapy using enercel","volume":"4","author":"Liang","year":"2011","journal-title":"J Acupunct Meridian Stud."},{"key":"B22","first-page":"187","article-title":"Effects of Sa-Am acupuncture treatment on a Als (amyotrophic lateral sclerosis) patient","volume":"29","author":"Lee","year":"2012","journal-title":"J Acupunct Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3831\/KPI.2010.13.1.121","article-title":"The follow-up study on patients of amyotrophic lateral sclerosis after 1 year","volume":"13","author":"Kim","year":"2010","journal-title":"J Pharmacopuncture."},{"key":"B24","first-page":"173","article-title":"2 Cases of amyotrophic lateral sclerosis (ALS) with oriental medical treatment evaluated by K-Alsfrs-R and Alsss","volume":"26","author":"Ryu","year":"2009","journal-title":"J Acupunct Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.2146\/ajhp060182","article-title":"How to write a patient case report","volume":"63","author":"Cohen","year":"2006","journal-title":"Am J Health Syst Pharm."},{"key":"B26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.injury.2006.02.001","article-title":"Grading the evidence: levels of evidence and grades of recommendation","volume":"37","author":"Petrisor","year":"2006","journal-title":"Injury."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e1320","DOI":"10.4088\/JCP.15f10377","article-title":"The Primary Outcome Measure and Its Importance in Clinical Trials","volume":"76","author":"Andrade","year":"2015","journal-title":"J Clin Psychiatry."},{"key":"B28","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1056\/NEJMp1511701","article-title":"Standardizing patient outcomes measurement","volume":"374","author":"Porter","year":"2016","journal-title":"N Engl J Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"c3920","DOI":"10.1136\/bmj.c3920","article-title":"Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review","volume":"341","author":"Cordoba","year":"2010","journal-title":"Bmj."},{"key":"B30","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1186\/s13063-020-04440-w","article-title":"Outcome reporting recommendations for clinical trial protocols and reports: a scoping review","volume":"21","author":"Butcher","year":"2020","journal-title":"Trials."},{"key":"B31","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1001\/archneurol.2009.1","article-title":"Defining survival as an outcome measure in amyotrophic lateral sclerosis","volume":"66","author":"Gordon","year":"2009","journal-title":"Arch Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"Rob 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Bmj."},{"key":"B33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jclinepi.2013.08.003","article-title":"The care guidelines: consensus-based clinical case report guideline development","volume":"67","author":"Gagnier","year":"2014","journal-title":"J Clin Epidemiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"781","DOI":"10.7326\/0003-4819-141-10-200411160-00009","article-title":"Better reporting of harms in randomized trials: an extension of the consort statement","volume":"141","author":"Ioannidis","year":"2004","journal-title":"Ann Intern Med."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.1019156\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T06:37:22Z","timestamp":1667457442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.1019156\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,3]]},"references-count":34,"alternative-id":["10.3389\/fneur.2022.1019156"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.1019156","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2022,11,3]]},"article-number":"1019156"}}